Literature DB >> 15046531

Diagnosis and treatment of ADHD in adults in primary care.

Brendan Montano1.   

Abstract

The prevalence rate of adult attention-deficit/hyperactivity disorder (ADHD) indicates that 4.5% of adults continue to exhibit ADHD from childhood. Most adult sufferers of ADHD have not been properly diagnosed or treated. The majority of adults with ADHD exhibit at least 1 comorbid psychiatric disorder, such as major depressive disorder, anxiety disorder, personality disorder, substance abuse disorder, or bipolar disorder. In many instances, such a disorder may offer the first clue to diagnosing an adult with ADHD. Comorbidities may, however, confound a proper ADHD diagnosis, so it is important to look for and establish an early (childhood) and persistent (lifelong) history of inattention or hyperactivity. The use of available standardized ADHD rating scales and checklists will then help the physician to differentiate between ADHD and other comorbid psychiatric disorders commonly seen in primary care. At present, there is no universally accepted and efficient standardized assessment tool for identifying adult ADHD in primary care. However, the Adult Self-Report Scale Screener may represent such a tool and may be used with ease in a busy office setting. Using such strategies, primary care providers are still able and encouraged to identify and treat adults with ADHD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15046531

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

1.  Challenges in identifying and managing attention-deficit/hyperactivity disorder in adults in the primary care setting: a review of the literature.

Authors:  Larry Culpepper; Gregory Mattingly
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 2.  Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder During Adolescence in the Primary Care Setting: A Concise Review.

Authors:  Khyati Brahmbhatt; Donald M Hilty; Mina Hah; Jaesu Han; Kathy Angkustsiri; Julie B Schweitzer
Journal:  J Adolesc Health       Date:  2016-05-18       Impact factor: 5.012

Review 3.  Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis.

Authors:  Kim Peterson; Marian S McDonagh; Rongwei Fu
Journal:  Psychopharmacology (Berl)       Date:  2007-11-17       Impact factor: 4.530

4.  Working Conditions, Work Productivity, Quality of Life, and Depressive Symptoms in Undiagnosed Adults with and without Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms During the COVID-19 Pandemic.

Authors:  Toru Nakai; Toshinaga Tsuji; Hiroshi Tsuda; Takuma Sotodate; Yuki Namba; Tatsuhiro Uenishi; Katsuhiko Iwasaki; Kinya Kokubo; Hiroaki Tomita
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-29       Impact factor: 2.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.